Dashenlin Pharmaceutical Group Co., Ltd. (603233)
Market Open
10 Aug, 06:57
SSE SSE Primary ¥
18. 23
+0.72
+4.1119%
¥
16.64B Market Cap
- P/E Ratio
1.24% Div Yield
11.9M Volume
- Eps
¥ 17.51
Previous Close Want to track 603233 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Dashenlin Pharmaceutical Group Co., Ltd. (603233) Statistics
Valuation metrics
Market Cap 16.64B
Enterprise value 15.67B
Trailing P/E (ttm) 15.5
Forward P/E -
PEG ratio 0.47
Price/Sales (ttm) 0.72
Price/Book (mrq) 2.53
Enterprise Value/Revenue 0.57
Enterprise Value/EBITDA 5.41
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.04M
Average volume (90 days) 7.68M
Price summary
52-Week low 14.39
52-Week high 21.78
Beta -
50-Day moving average 17.7
200-Day moving average 18.12
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.83
Trailing annual dividend yield 0.0474%
5-Year annual dividend yield -
Payout ratio 0.6
Dividend Date 26 Jun 2026
Ex-Dividend Date 26 Jun 2026
Last split factor 1:1
Last split Date 9 Jun 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.05%
Operating margin 0.07%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.17%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 24.23
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.26
Total debt (mrq) -
Total Debt/Equity (mrq) 0.33
Current ratio (mrq) 0.93%
Book value per share (mrq) 8.08
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
